Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells

Tumor treating fields (TTFields) represent a novel FDA-approved treatment modality for patients with newly diagnosed or recurrent glioblastoma multiforme. This therapy applies intermediate frequency alternating electric fields with low intensity to the tumor volume by the use of non-invasive transdu...

Full description

Bibliographic Details
Main Authors: Eric Neuhaus, Lisa Zirjacks, Katrin Ganser, Lukas Klumpp, Uwe Schüler, Daniel Zips, Franziska Eckert, Stephan M. Huber
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Cancers
Subjects:
glioma
alternating electric field therapy
Ca2+ signaling
programmed cell death
clonogenicity
L-type Ca2+ channel
benidipine
Online Access:http://www.mdpi.com/2072-6694/11/1/110

Internet

http://www.mdpi.com/2072-6694/11/1/110

Similar Items